share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Novavax | 4: Statement of changes in beneficial ownership of securities

諾瓦瓦克斯醫藥 | 4：持股變動聲明
SEC announcement ·  03/12 20:49
Moomoo AI 已提取核心訊息
On March 10, 2024, James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a transaction involving the company's common stock. Kelly exercised options, acquiring 4,608 shares, and subsequently sold 2,226 shares at a price of $5.45 each. The total market value of the disposed shares amounted to $12,131.70. Following these transactions, Kelly directly holds 13,285 shares of Novavax common stock.
On March 10, 2024, James Patrick Kelly, EVP, CFO, and Treasurer of Novavax Inc, completed a transaction involving the company's common stock. Kelly exercised options, acquiring 4,608 shares, and subsequently sold 2,226 shares at a price of $5.45 each. The total market value of the disposed shares amounted to $12,131.70. Following these transactions, Kelly directly holds 13,285 shares of Novavax common stock.
2024年3月10日，Novavax Inc執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利完成了一項涉及該公司普通股的交易。凱利行使了期權，收購了4,608股股票，隨後以每股5.45美元的價格出售了2,226股股票。已處置股份的總市值爲12,131.70美元。在這些交易之後，凱利直接持有13,285股Novavax普通股。
2024年3月10日，Novavax Inc執行副總裁、首席財務官兼財務主管詹姆斯·帕特里克·凱利完成了一項涉及該公司普通股的交易。凱利行使了期權，收購了4,608股股票，隨後以每股5.45美元的價格出售了2,226股股票。已處置股份的總市值爲12,131.70美元。在這些交易之後，凱利直接持有13,285股Novavax普通股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息